Cancer cells may also downregulate the expression of antigens on their surface that are normally recognized by immune cells, rendering them unidentifiable; concurrently, they can express immune checkpoint molecules like PD-L1, which upon binding to PD-1 on T cells, inhibit T cell activation, leading to immune tolerance against cancer cells (78). This evidence concerns the gene CD274 and cancer.